PUBLISHER: The Business Research Company | PRODUCT CODE: 1605571
PUBLISHER: The Business Research Company | PRODUCT CODE: 1605571
Effervescent and chewing tablets are oral dosage forms designed for rapid disintegration and absorption. Effervescent tablets dissolve in water, releasing carbon dioxide to create a fizzy solution that enhances absorption speed. In contrast, chewing tablets are formulated to be chewed before swallowing, allowing for direct contact with saliva and a quicker onset of action.
The primary types of effervescent and chewing tablets are effervescent tablets and chewing tablets. An effervescent tablet is designed to dissolve in water, releasing carbon dioxide to form a fizzy solution, and is commonly used for fast-acting medications, nutritional supplementation, and electrolyte replacement. These products are distributed through various channels, including pharmacies and drug stores, supermarkets and hypermarkets, online retailers, and healthcare practitioners. They serve diverse applications such as healthcare, nutritional supplementation, weight management, and cosmetics, catering to a wide range of users, including adults, children, seniors, and athletes.
The effervescent and chewing tablet market research report is one of a series of new reports from The Business Research Company that provides effervescent and chewing tablet market statistics, including effervescent and chewing tablet industry global market size, regional shares, competitors with a effervescent and chewing tablet market share, detailed effervescent and chewing tablet market segments, market trends and opportunities, and any further data you may need to thrive in the effervescent and chewing tablet industry. This effervescent and chewing tablet market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The effervescent and chewing tablet market size has grown rapidly in recent years. It will grow from $3.87 billion in 2023 to $4.36 billion in 2024 at a compound annual growth rate (CAGR) of 12.6%. The growth during the historic period can be attributed to several factors, including the rising demand for fast-dissolving supplements, increasing consumer awareness of nutritional deficiencies, the growing fitness and wellness trends, the rise in self-medication practices, and higher disposable incomes.
The effervescent and chewing tablet market size is expected to see rapid growth in the next few years. It will grow to $7.05 billion in 2028 at a compound annual growth rate (CAGR) of 12.7%. The anticipated growth in the forecast period can be attributed to several factors, including the increasing demand for personalized nutrition, a rising adoption of plant-based supplements, a growing emphasis on sustainable packaging, heightened demand for immune-boosting supplements, and increased awareness of eco-friendly products. Key trends expected during this period include a rise in vegan and organic supplements, growth in clean-label effervescent products, a surge in demand for sugar-free formulations, the popularity of single-serve effervescent formats, and a focus on enhancing the bioavailability of ingredients.
The increasing prevalence of digestive disorders is projected to drive the growth of the effervescent and chewing tablet market in the foreseeable future. The rise in digestive issues is largely attributed to factors such as unhealthy dietary habits, high stress levels, sedentary lifestyles, an overreliance on medications, and a growing consumption of processed foods. Effervescent and chewing tablets offer rapid and convenient relief for digestive disorders such as indigestion, bloating, and heartburn, making them a preferred option for managing mild gastrointestinal discomfort. For example, the Impact of IBD Report 2023, published by the IBD Clinical and Research Centre in September 2023, noted that over 320,000 individuals in Canada have inflammatory bowel disease (IBD), with a prevalence of 825 per 100,000 people. This figure is expected to rise by 2.44% annually, projecting that by 2035, approximately 470,000 Canadians will be living with IBD. Thus, the rising incidence of digestive disorders is significantly fueling the growth of the effervescent and chewing tablet market.
Key players in the effervescent and chewing tablet markets are concentrating on developing innovative moisture-resistant manufacturing techniques to maintain their competitive edge. Moisture-resistant manufacturing processes are designed to protect products from damage or degradation due to moisture exposure, thereby ensuring durability and reliability. For instance, in April 2022, Health Innovations Ltd., a UK-based healthcare supplement company, launched EfferShield, a groundbreaking manufacturing technology for effervescent products. This patented innovation minimizes reliance on conventional plastic tubes, offering a more sustainable alternative. EfferShield features a specialized moisture-resistant barrier that ensures product stability while facilitating the creation of new formulations. It also supports eco-friendly packaging options, such as pouches and stick packs, making it suitable for single-use applications.
In January 2022, Kelso Pharma, a UK-based specialty pharmaceutical company, acquired Stirling Anglian Pharmaceuticals Ltd. for an undisclosed amount. This acquisition aims to enhance Kelso Pharma's platform in the UK for expanding its pan-European specialty pharmaceutical business through further acquisitions, product licensing, and innovations in cost-effective, patient-focused medicines. Stirling Anglian Pharmaceuticals Ltd. specializes in providing effervescent and chewing tablets.
Major companies operating in the effervescent and chewing tablet market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Sanofi SA, Abbott Laboratories, Boehringer Ingelheim, Teva Pharmaceutical Industries, Amway Corp., Sun Pharmaceutical Industries Ltd., Herbalife International Inc., Dr Reddy's Laboratories Ltd., Leo Nutriscience, Bliss GVS Pharma Limited, Amerilab Technologies Inc., Tower Laboratories Ltd., Vitabiotics Ltd., Losan Pharma GmbH, Biocaro Pharmaceutical, Nutra Healthcare Private Limited, Vovantis Laboratories Pvt. Ltd., BHI Biohealth International GmbH, Nutrilo GmbH, PharmaEstica Manufacturing OU, The Himalayan Organics, FixupHealth, The Vitamin Company
North America was the largest region in the effervescent and chewing tablet market in 2023. The regions covered in the effervescent and chewing tablet market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the effervescent and chewing tablet market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The effervescent and chewing tablet market consists of sales of vitamin and mineral supplements, pain relief tablets, and gastrointestinal relief products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Effervescent And Chewing Tablet Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on effervescent and chewing tablet market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for effervescent and chewing tablet ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The effervescent and chewing tablet market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
The impact of higher inflation in many countries and the resulting spike in interest rates.
The continued but declining impact of COVID-19 on supply chains and consumption patterns.